Patent Assignment
Reel/Frame 051041/0478
Assignment of Assignor's Interest
Recorded: 2019-11-15
Pages: 45
Assignor
BIOELECTRON TECHNOLOGY CORPORATION
Executed: 2019-10-25
Assignee
PTC THERAPEUTICS, INC.
100 CORPORATE COURT, SOUTH PLAINFIELD, NEW JERSEY, 07080-2449
Covered Properties
(56)
Methods and Compositions for Treatment of Inflammation and Oxidative Stress
PCT:
PCT/US2018/027682 ↗
Methods for the Prevention and Treatment of Cerebral Ischemia Using Non-Alpha Tocopherols
Identifying Therapeutic Compounds Based on Their Physical-Chemical Properties
7,8-Bicycloalkyl-Chroman Derivatives
Chroman Derivatives
Tail Variants of Redox-Active Therapeutics for Treatment of Mitochondrial Diseases and Other Conditions and Modulation of Energy Biomarkers
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
7,8-Bicycloakyl-Chroman Derivatives
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Process for the Production of Alpha-Tocotrienol and Derivatives
(Het)Aryl-P-Quinone Derivatives for Treatment of Mitochondrial Diseases
2-Substituted-P-Quinone Derivatives for Treatment of Oxidative Stress Diseases
2-Heterocyclylaminoalkyl-(P-Quinone) Derivatives for Treatment of Oxidative Stress Diseases
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
Treatment of Oxidative Stress Disorders Including Contrast Nephropathy, Radiation Damage and Disruptions in the Function of Red Cells
Chroman Derivatives
Process for the Production of Alpha-Tocotrienol and Derivatives
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Resorufin Derivatives for Treatment of Oxidative Stress Disorders
Treatment of Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy with Tocotrienol Quinones
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
Catechol Derivatives for Treatment of Oxidative Stress Diseases
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
2-Heterocyclylaminoalkyl-(P-Quinone) Derivatives for Treatment of Oxidative Stress Diseases
Methods for Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Benzoquinone Derivatives for Treating Oxidative Stress Disorders
(Het)Aryl-P-Quinone Derivatives for Treatment of Mitochondrial Diseases
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Alkyl-Heteroaryl Substituted Quinone Derivatives for Treatment of Oxidative Stress Disorders
Resorufin Derivatives for Treatment of Oxidative Stress Disorders
Phenazine-3-One and Phenothiazine-3-One Derivatives for Treatment of Oxidative Stress Disorders
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
Methods for Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Side-Chain Variants of Redox-Active Therapeutics for Treatment of Mitochondrial Diseases and Other Conditions and Modulation of Energy Biomarkers
Process for the Production of Alpha-Tocotrienol and Derivatives
Treatment of Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy with Tocotrienol Quinones
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
4-(Pquinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
Methods for Selective Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Polymorphic and Amorphous Forms of (R)-2-Hydroxy-2-Methyl-4-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dienyl)Butanamide
Distributed systems and methods for learning about a bioprocess from redox indicators and local conditions
Application:
15/675,364 →
Publication:
US 2019/0050532
Redox-related context adjustments to a reference bioprocess model used in learning systems and methods based on redox indicators
Application:
15/702,885 →
Publication:
US 2019/0050533
Redox-related context adjustments to a bioprocess monitored by learning systems and methods based on redox indicators
Application:
15/785,415 →
Publication:
US 2019/0048306
Treatment of Methylmalonic Aciduria, Isovaleric Aciduria, and Other Organic Acidurias with Tocotrienol Quinones
Application:
16/019,363 →
Publication:
US 2018/0303770
Treatment of Oxidative Stress Disorders Including Contrast Nephropathy, Radiation Damage and Disruptions in the Function of Red Cells
Application:
16/020,882 →
Publication:
US 2018/0303767
Methods for Selective Oxidation of Alpha Tocotrienol in the Presence of Non-Alpha Tocotrienols
Improved Methods for Enriching Alpha-Tocotrienol from Mixed Tocol Compositions
Fluoroalkyl, Fluoroalkoxy, Phenoxy, Heteroaryloxy, Alkoxy, and Amine 1,4-Benzoquinone Derivatives for Treatment of Oxidative Stress Disorders
Process for the Production of Alpha-Tocotrienol and Derivatives
Treatment of Pervasive Developmental Disorders with Redox-Active Therapeutics
Treatment of Leigh Syndrome and Leigh-Like Syndrome with Tocotrienol Quinones
Application:
16/213,927 →
Publication:
US 2019/0216749
4-(P-Quinonyl)-2-Hydroxybutanamide Derivatives for Treatment of Mitochondrial Diseases
2-Substituted Amino-Naphth (1,2-D) Imidazol-5-One Compounds or Pharmaceutically Acceptable Salts Thereof
Polymorphic and Amorphous Forms of (R)-2-Hydroxy-2-Methyl-4-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dienyl)Butanamide
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 30, 2009
From: WESSON, KIERON E.; HINMAN, ANDREW W.; JANKOWSKI, ORION D.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 023721/0621 →
Assignment of Assignor's Interest
Jun 14, 2013
From: AMPERE LIFE SCIENCES, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 030619/0221 →
Assignment of Assignor's Interest
Jun 14, 2013
From: AMPERE LIFE SCIENCES, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 030619/0215 →
Assignment of Assignor's Interest
Jun 14, 2013
From: AMPERE LIFE SCIENCES, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 030619/0186 →
Assignment of Assignor's Interest
Jun 14, 2013
From: AMPERE LIFE SCIENCES, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 030619/0197 →
Assignment of Assignor's Interest
Sep 3, 2015
From: AMPERE LIFE SCIENCES, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 036491/0693 →
Assignment of Assignor's Interest
Feb 7, 2017
From: AMPERE LIFE SCIENCES, INC.
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 041197/0269 →
Change of Name
Feb 8, 2017
From: EDISON PHARMACEUTICALS, INC.
To: BIOELECTRON TECHNOLOGY CORPORATION
Reel/Frame 041660/0644 →
Assignment of Assignor's Interest
Apr 12, 2019
From: TRIMMER, JEFFERY K.; SHRADER, WILLIAM D.; HINMAN, ANDREW W.; HOLST, CHARLES R.
To: BIOELECTRON TECHNOLOGY CORPORATION
Reel/Frame 048876/0569 →
Assignment of Assignor's Interest
Apr 18, 2019
From: MILLER, GUY
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 048932/0800 →
Change of Name
Apr 19, 2019
From: EDISON PHARMACEUTICALS, INC.
To: BIOELECTRON TECHNOLOGY CORPORATION
Reel/Frame 048949/0302 →
Security Interest
Oct 28, 2022
From: PTC THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 061803/0878 →
Termination and Release of Patent Security Agreement @ Reel 061803 and Frame 0878
Oct 20, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 065303/0163 →